BackParanovus Entertainment Technology Overview

Paranovus Entertainment Technology EBIT

Track Paranovus Entertainment Technology's EBIT ($-4.3M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow

Quarterly EBIT

-$2.75M
↓ 381.01% YoY

As of Mar 31, 2026

Annual EBIT (TTM)

-$4.29M
↓ 474.26% YoY

Trailing 12 months ending Mar 31, 2026

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

Paranovus Entertainment Technology (PAVS) FAQ

The latest EBIT for PAVS is $-4.3M as of March 2026. That compares with $1.1M in the prior-year period — down 474.3% year over year. That is below the Healthcare sector average of $110B. Investors often review this figure alongside Paranovus Entertainment Technology's historical trend and sector peers before judging valuation or financial health.

Over the past year, PAVS's EBIT moved from $1.1M to $-4.3M — a 474.3% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Paranovus Entertainment Technology's operating scale or balance-sheet position.

Against Healthcare companies, PAVS currently prints $-4.3M for EBIT, while the sector average sits near $110B. That is roughly 100.0% below the sector mean. Large gaps often invite a closer look at Paranovus Entertainment Technology's growth, margins, and balance sheet.

A EBIT figure of $-4.3M for PAVS is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The Healthcare average is about $110B. Explore the charts below for those layers of context.

After noting PAVS's EBIT ($-4.3M), review year-over-year change from $1.1M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.